HTG MOLECULAR DIAGNOSTICS, INC (53) | Business Operations (4)
Browse by Subcategory
Recent Contracts
-
Controlled Equity OfferingSM Sales Agreement, dated as of November 14, 2019, by and between HTG Molecular Diagnostics, Inc. and Cantor Fitzgerald & Co
(Filed With SEC on November 15, 2019)
-
First Amendment to Amended and Restated IVD Test Development and Component Supply Agreement, dated April 23, 2019, by and between Illumina, Inc. and the Registrant
(Filed With SEC on May 9, 2019)
-
Fourth Amendment to Statement of Work No. 2, dated February 15, 2019, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and...
(Filed With SEC on May 9, 2019)
-
Sales Agreement, dated as of March 13, 2019, by and between HTG Molecular Diagnostics, Inc. and Cowen and Company, LLC
(Filed With SEC on March 13, 2019)